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A
s this issue of Science & Practice Perspectives goes
to press, NIDA’s third “Blending Clinical Practice
and Research”conference is about to begin in
Denver. Hundreds of producers of recovery and creators
of new knowledge on drug abuse are gathering to share
and combine their expertise in plenary sessions, topic dis-
cussions, and skills-building workshops on a wide range
of critically important topics. 
“Blending” is NIDA’s short name for some of its most
important work. By blending, we mean the integrated
research-practice partnership so necessary to achieve our
full potential to relieve the suffering and waste of human
life caused by drug abuse and addiction. In “Blending”
meetings, researchers, clinicians, other care providers,
social workers, criminal justice officers, and community
leaders bring their observations, insights, viewpoints, and
priorities collectively to bear in advancing our under-
standing of drug abuse and addiction and our ability to
treat and prevent it.  Experience has shown that these col-
legial discussions are a potent catalyst for progress.
NIDA initiatives that focus directly on facilitating and
improving research-practice dialogue take many forms.
The fullest expression of  blending in action is the Clinical
Trials Network. In this nationwide consortium, researchers
and providers work together to set research priorities and
plan studies specifically to resolve issues that community
treatment and prevention programs identify as top-
priority. They conduct the studies together in community
settings, ensuring that the results are readily adaptable
for rapid implementation in a variety of treatment settings.
Science & Practice Perspectives brings the robust research-
practice exchanges that are the essence of blending to the
page (and the Web), and to research centers and treat-
ment programs nationwide and around the world. We hope
S&PP will stimulate and inspire you, and that you too join
in the growing research-practice dialogue. Only in this way
can we realize the full power of  rapidly advancing science
and current clinical experience to improve the health and
well-being of everyone affected by substance abuse.
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